Swedencare Ab · OMXSTO:SECARE

Swedencare Ab — Q3 2023 Earnings Presentation

13 slides from Swedencare Ab's earnings presentation, Oct 25, 2023

  1. Slide 1: Q3 Interim Report July - September 2023

    Q3 INTERIM REPORT July - September 2023 Presentation CEO Håkan Lagerberg CFO Jenny Graflind

  2. Slide 2: Q3 2023 Highlights

    Q3 2023 Highlights 17% organic growth with strong cash flow Sales record both Quarter and Month – Strong Pet Retail and Online Organic growth 17% Strong cash flow – 99% cash conversion from EBITDA, 75 MSEK amortization and Net debt/EBITDA below 3 All regions delivering double digit growth Both brand

  3. Slide 3: ESG 2023

    ESG 2023 Implemented a sustainability platform to collect and analyze data from the entire group. Started working on a materiality analysis where we go through the most important sustainability priorities. Motivated employees are our most important asset, we work with ongoing improvement on work env

  4. Slide 4: Net sales and Operational EBITDA (MSEK)

    Operational Net sales (MSEK) EBITDA (MSEK) Q3 2022 Q3 2023 700 140 600 120 35% 25% 500 100 400 80 300 21,0% 22,8% 60 200 40 20 100 0 0 Q3 2022 Q3 2023

  5. Slide 5: Key Performance Indicators Q3 2023

    Key Performance Indicators Q3 2023

  6. Slide 6: Key Performance Indicators YTD 2023

    Key Performance Indicators YTD 2023

  7. Slide 7: Rolling 4 Quarters

    Rolling 4 Quarters Qi Q2 238 Q4 at @ a3 24 Qt Q 3 24 Qi Q a 2020 2021 2022 2023 HE Net revenue EBITDA (Operational EBITDA #8 SWEDENCARE

  8. Slide 8: Product- and Brandsplit

    Product- and Brandsplit OTHER pancun — BY ccna nutravet" 3% — @%) 11% 17% 4% Pet MD (7%) (8%) 3%) 40% (12%) PlaqueOff 13% oe TOPICALS/ AV Naturvet' DERMATOLOGY (11%) Q3 2023 29% Q3 2023 23% (25%) PRIVATE/CO LABEL (83%) 17% s% (15%) ‘0 (48%) 5% (7%) WEDENCARE

  9. Slide 9: Net Sales by region (470,0 MSEK)

    Net Sales by region (470,0 MSEK) North America – 78% of total revenue • Strong quarter in Pet Retail and Online, Vet a bit soft but collaborations with Patterson and MWI starting to show growth • Vetio South – flat and still low single digit profitability – new GM, expansion of SC line, Q4 will show

  10. Slide 10: Net Sales by region (111,5 MSEK)

    Net Sales by region (111,5 MSEK) Europe – 19% of total revenue • Market demand high on all channels • Continued strong Online sales • All European markets double digit growth and some exceptional, Spain +260% and Nutravet 100% • Vetio UK (CVP), best Q, co-op with Vetio S and SDC Ireland • SDC Irelan

  11. Slide 11: Net Sales by region (20,5 MSEK)

    Net Sales by region (20,5 MSEK) Rest of the World – 3% of total revenue • Doubling of sales, both products and development project for Vetio N from Chinese customer • ProDen PlaqueOff® had a strong quarter with Asia, several countries in South America and Australia. Mexico new market • nutravet® Pol

  12. Slide 12: Priorities 2023/2024

    Priorities 2023/2024 Growth and profitability and lowering debt level Deliver on strong pipeline Continued move from external to internal Product launches and development Solidifying and developing relationships with major customers Co-op and M&A opportunities

  13. Slide 13: Thank You for participating! Q&A

    Thank You for participating! Q&A

Swedencare — Q3 2023 Earnings Presentation on 6ix